• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Lupin receives U.S. FDA approval for Brimonidine Tartrate Ophthalmic Solution

    EXPRESSPHARMA

    Lupin`s Generics Brimonidine Tartrate Receives Approval in US

    FDA

    Bausch + Lomb To Present New Data At European Dry Eye Society 2024 Congress

    BUSINESSWIRE

    Upsher Smith Labs Generic Brimonidine Tartrate Receives Approval in US

    FDA

    Glenmark receives ANDA approval for Brimonidine Tartrate & Timolol Maleate

    INDINPHARMAPOST

    Glenmark receives US FDA approval for brimonidine tartrate and timolol maleate

    PHARMABIZ

    Glenmark`s Generic Brimonidine Tartrate;Timolol Receives Approval in the U.S.

    FDA

    Dr. Reddy`s Generic Brimonidine Tartrate Receives Approval in the U.S.

    FDA

    Perrigo`s Generic Brinzolamide Receives Approval in the U.S.

    FDA

    Alembic`s Generic Brimonidine Tartrate Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of March 15, 2023

    FDA

    Apotex issues recall of eye treatment over cracked bottle caps

    ENDPTS

    Apotex Corp. Issues Voluntary Nationwide Recall of Brimonidine Tartrate Ophthalmic Solution

    FDA

    Slayback`s Generic Brimonidine Tartrate Receives Tentative Approval in U.S.

    FDA

    Apotex`s Generic Brimonidine Tartrate Receives Approval in the U.S.

    FDA

    Upsher`s Generic Brimonidine Tartrate and Timolol Maleate Receives Approval in the U.S.

    FDA

    Akorn`s Generic Brimonidine Tartrate, Timolol Maleate Receives Approval in the U.S.

    FDA

    LENZ Announces Topline Data from PhII Trial of LNZ100 & LNZ101

    BUSINESSWIRE

    Watson`s Generic Brimonidine Tartrate, Timolol Maleate Receives Approval in the U.S.

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Simbrinza (Brinzolamide and Brimonidine Tartrate)

    FDA

    The FDA says Ocugen needs to hand over results from a 2019 study

    FIERCEPHARMA

    Apotex`s Generic Brimonidine Tartrate;Timolol Receives Approval in the U.S.

    FDA

    Sandoz`s Generic Brimonidine Tartrate and Timolol Maleate Receives Approval in the U.S.

    FDA

    Apotex`s Generic Brimonidine Tartrate Receives Approval in the U.S.

    FDA

    Apotex`s Generic Dasatinib Receives Approval in the US

    FDA

    Padagis Israel`s Generic Brimonidine Tartrate Receives Approval in the US

    FDA

    Enforcement Report - Week of July 15

    FDA

    Launch of a New Combination Ophthalmic Solution for the Treatment of Glaucoma

    PRESS RELEASE

    Enforcement Report - Week of April 3, 2019

    FDA

    Somerset Theraps` Generic Brimonidine Tartrate Receives Approval in US

    FDA

    Indoco Remedies Fails EDQM Inspection

    EDQM

    Sandoz Inc`s Generic Brimonidine Tartrate Receives Approval in US

    FDA

    Imprimis Pharmaceuticals Receives FDA Warning Letter

    FDA

    FDA Approves Bausch + Lomb’s LUMIFY

    BIOSPECTRUM

    Enforcement Report - Week of November 22, 2017

    FDA

    Ocugen FDA Acceptance of Investigational NDA for OCU310 brimonidine/steroid

    PR NEWSWIRE

    Perrigo Uk Finco’s Generic Brimonidine Receives Approval In US

    FDA

    Allergan takes on preventable blindness with nationwide vision-screening push

    FIERCE PHARMA

    Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.